ExLibris header image
SFX Logo
Title: The entry of entry inhibitors: A fusion of science and medicine
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Moore, J P yr:2003


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Esté, José A A. "HIV entry inhibitors." The lancet 370.9581 (2007): 81-8. Link to SFX for this item
2. Mueller, A. "Pharmacological characterization of the chemokine receptor, CCR5." British journal of pharmacology (2002): 1033-43. Link to Full Text for this item Link to SFX for this item
3. HEINZINGER, N. "THE VPR PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFLUENCES NUCLEAR-LOCALIZATION OF VIRAL NUCLEIC-ACIDS IN NONDIVIDING HOST-CELLS." Proceedings of the National Academy of Sciences of the United States of America 91.15 (1994): 7311-7315. Link to Full Text for this item Link to SFX for this item
4. Harrison, Stephen C C. "Discovery of antivirals against smallpox." Proceedings of the National Academy of Sciences of the United States of America 101.31 (2004): 11178-11192. Link to Full Text for this item Link to SFX for this item
5. Lange, Joep A. "Peptide inhibitors of virus–cell fusion: enfuvirtide as a case study in clinical discovery and development." The Lancet infectious diseases 4.7 (2004): 426-436. Link to SFX for this item
6. Fätkenheuer, G. "Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1." Nature medicine 11.11 (2005): 1170-2. Link to Full Text for this item Link to SFX for this item
7. De Clercq, E. "Antiviral agents active against influenza A viruses." Nature reviews. Drug discovery 5.12 (2007): 1015-25. Link to Full Text for this item Link to SFX for this item
8. Leonard, J. T. "The HIV entry inhibitors revisited." Current medicinal chemistry 13.8 (2006): 911-934. Link to SFX for this item
9. Aquaro, S. "Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment." The journal of antimicrobial chemotherapy 58.4: 714-22. Link to SFX for this item
10. Bray, M. "Understanding smallpox vaccination." The Journal of infectious diseases 203.8 (2011): 1037-1039. Link to Full Text for this item Link to SFX for this item
11. Spearman, P. "Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly." Journal of virology 68.5 (1994): 3232-42. Link to Full Text for this item Link to SFX for this item
12. Agostini, I. "Phosphorylation of Vpr regulates HIV type 1 nuclear import and macrophage infection." AIDS research and human retroviruses 18.4 (2002): 283-288. Link to SFX for this item
13. Emerman, M. "HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection." Genes & development 12.2 (1997): 175-85. Link to Full Text for this item Link to SFX for this item
14. Letai, Anthony G G. "Smallpox and smallpox vaccination." New England Journal of Medicine, The 348.19 (2003): 1920-5. Link to SFX for this item
15. Schmid, Sandra L L. "Days and knights discussing membrane dynamics in endocytosis: meeting report from the Euresco/EMBL Membrane Dynamics in Endocytosis, 6--11 October in Tomar, Portugal." Traffic (2001): 77-85. Link to Full Text for this item Link to SFX for this item
16. Maldarelli, F. "Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein." Journal of virology 64.6 (1993): 5056-61. Link to Full Text for this item Link to SFX for this item
17. De Clercq, E. "Antivirals and antiviral strategies." Nature reviews. Microbiology 2.9: 704-720. Link to SFX for this item
18. Seibert, C. "Small-molecule antagonists of CCR5 and CXCR4: A promising new class of anti-HIV-1 drugs." Current pharmaceutical design 10.17 (2004): 2041-62. Link to SFX for this item
19. Breman, Joel G G. "Diagnosis and management of smallpox." New England Journal of Medicine, The 346.17 (2002): 1300-8. Link to SFX for this item
20. Soriano, V. "Dynamics of enfuvirtide resistance in HIV-infected patients during and after long-term enfuvirtide salvage therapy." Journal of clinical virology 34.4 (2005): 295-301. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced